Full Paper
4.16 (m, 2H), 4.95 (dq, J=10.3, 1.5 Hz, 1H), 5.03 (dq, J=17.3,
1.5 Hz, 1H), 5.80 (ddt, J=17.3, 10.3, 6.1 Hz, 1H), 7.36–7.44 (m, 6H),
7.66–7.69 ppm (m, 4H); 13C NMR (CDCl3, 75 MHz): d=11.8, 14.4,
19.2, 26.9, 27.3, 27.5, 27.6, 31.3, 45.3, 59.9, 61.8, 114.7, 127.8, 129.8,
133.8, 135.7, 137.8, 171.9 ppm; HRMS (ESI pos): m/z calcd for
C28H38O3NaSi+ [M+Na]+: 473.2488; found: 473.2480.
(m, 11H), 1.49–1.65 (m, 3H), 1.69 (d, J=6.1 Hz, 1H), 2.14 (d, J=
6.1 Hz, 1H), 2.43 (s, 3H), 2.73–2.79 (m, 1H), 4.11 (q, J=7.1 Hz, 2H),
6.00 (s, 1H), 7.31 (d, J=8.0 Hz, 2H), 7.77 ppm (d, J=8.0 Hz,
2H);13C NMR (CDCl3, 100 MHz): d=13.9, 14.2, 14.4, 18.2, 21.7, 22.9,
23.1, 29.2, 30.0, 31.2, 32.7, 33.8, 35.2, 39.1, 60.9, 127.1, 127.3, 130.0,
139.7, 144.2, 156.9, 171.1 ppm; HRMS (ESI pos): m/z calcd for
C24H36O4SNa+ [M+Na]+ 443.2232; found: 443.2274.
(1S*,2S*,3R*)-Ethyl 3-allyl-2-[2-(benzyloxy)ethyl]-2-methylcyclo-
propanecarboxylate (3r) was prepared according to procedure
A: Eluent (hexanes/Et2O 95:5); yield: 68% (yellowish oil); Rf =0.42
(hexanes/Et2O 95:5); 1H NMR (CDCl3, 300 MHz): d=1.12–1.20 (m,
7H), 1.48 (d, J=8.9 Hz, 1H), 1.58 (td, J=6.8, 2.1 Hz, 2H), 2.31–2.37
(m, 2H), 3.51 (t, J=6.8 Hz, 2H), 3.95–4.07 (m, 2H), 4.42 (s, 2H), 4.88
(dq, J=10.2, 1.7 Hz, 1H), 4.97 (dq, J=17.2, 1.7 Hz, 1H), 5.74 (ddt,
J=17.2, 10.2, 6.3 Hz, 1H), 7.17–7.30 ppm (m, 5H); 13C NMR (CDCl3,
75 MHz): d=11.9, 14.5, 27.1, 27.3, 27.6, 31.4, 42.5, 59.9, 68.3, 73.2,
114.7, 127.6, 127.7, 128.4, 137.8, 138.5, 171.7 ppm; HRMS (ESI pos):
(1S*,2S*,3R*)-Ethyl 2-butyl-2-ethyl-3-[(E)-1-tosylhex-1-en-2-yl]cy-
clopropanecarboxylate (3x) was prepared according to proce-
dure C: Eluent (hexanes/Et2O 95:5); yield: 43% isolated (colorless
oil); Rf =0.15 (hexanes/Et2O 95:5); 1H NMR (CDCl3, 300 MHz): d=
0.79–0.90 (m, 9H), 1.01 (q, J=7.2 Hz, 2H), 1.21–1.44 (m, 12H),
1.49–1.54 (m, 2H), 1.66 (d, J=6.3 Hz, 1H), 2.17 (d, J=6.3 Hz, 1H),
2.41 (s, 3H), 2.87–2.97 (m, 1H), 4.09 (q, J=7.2 Hz, 2H), 6.00 (s, 1H),
7.31 (d, J=8.2 Hz, 2H), 7.75 ppm (d, J=8.2 Hz, 2H); 13C NMR
(CDCl3, 100 MHz): d=11.0, 14.0, 14.3, 14.5, 21.8, 23.1, 23.2, 23.7,
29.1, 29.3, 30.6, 31.2, 33.0, 39.4, 40.3, 61.0, 127.2, 127.4, 130.0,
139.8, 144.3, 157.0, 171.1; HRMS (ESI pos): m/z calcd for
C25H38O4SNa+ [M+Na]+ 457.2389; found: 457.2364.
m/z calcd for C19H27O3 [M+H]+: 303.1960; found: 303.1971.
+
(1S*,2S*,3R*)-Ethyl 2-hexyl-2-methyl-3-(propa-1,2-dien-1-yl)cyclo-
propanecarboxylate (3s) was prepared according to procedure
A: Eluent (hexanes/Et2O 95:5); yield: 63% (yellowish oil); Rf =0.63
(hexanes/Et2O 95:5); 1H NMR (CDCl3, 300 MHz): d=0.87 (t, J=
6.6 Hz, 3H), 1.15–1.18 (m, 1H), 1.22 (s, 3H), 1.24–1.38 (m, 12H),
1.65 (d, J=8.5 Hz, 1H), 1.73–1.79 (m, 1H), 4.06–4.14 (m, 2H), 4.74
(d, J=6.7 Hz, 2H), 5.52 ppm (dt, J=9.6, 6.7 Hz, 1H); 13C NMR
(CDCl3, 75 MHz): d=12.0, 14.2, 14.5, 22.8, 26.3, 29.4, 30.2, 30.3,
31.7, 32.0, 42.6, 60.1, 75.3, 85.9, 171.2, 210.4 ppm; HRMS (ESI pos):
(1S*,2R*,3S*)-Ethyl 3-allyl-2-hexyl-2-methylcyclopropanecarboxy-
late (3manti) was prepared according to procedure D: Eluent (hex-
anes/Et2O 95:5); yield: 63% (yellowish oil); Rf =0.55 (hexanes/Et2O
1
95:5); H NMR (CDCl3, 400 MHz): d=0.84 (t, J=6.8 Hz, 3H), 1.10 (s,
3H), 1.18–1.25 (m, 11H), 1.29–1.54 (m, 4H), 2.02–2.09 (m, 1H),
2.13–2.20 (m, 1H), 4.08 (q, J=7.2 Hz, 2H), 4.96 (d, J=10.1 Hz, 1H),
5.02 (d, J=17.2 Hz, 1H), 5.81 ppm (ddt, J=17.2, 10.1, 6.2 Hz, 1H);
13C NMR (CDCl3, 100 MHz): d=14.1, 14.4, 18.4, 22.7, 26.9, 29.5, 29.5,
31.9, 32.0, 32.4, 32.7, 34.3, 60.2, 115.0, 137.2, 172.8 ppm; HRMS (ESI
m/z calcd for C16H27O2 [M+H]+: 251.2011; found: 251.2009.
+
(1S*,5R*,6S*)-6-Hexyl-4,4,6-trimethyl-3-oxabicyclo[3.1.0]hexan-2-
one (3t) was prepared according to procedure A: Eluent (hex-
anes/Et2O 95:5); yield: 79% (yellowish oil); Rf =0.17 (hexanes/Et2O
95:5); 1H NMR (CDCl3, 300 MHz): d=0.86 (t, J=6.8 Hz, 3H), 1.00–
1.12 (m, 1H), 1.21–1.27 (m, 7H), 1.28 (s, 3H), 1.34–1.39 (m, 2H),
1.42 (s, 6H), 1.72 (d, J=6.0 Hz, 1H), 1.97 ppm (d, J=6.0 Hz, 1H);
13C NMR (CDCl3, 75 MHz): d=14.2, 14.7, 22.7, 22.7, 26.4, 29.3, 29.5,
31.0, 31.8, 31.8, 38.5, 40.3, 83.0, 174.4 ppm; HRMS (ESI pos): m/z
pos): m/z calcd for C16H29O2 [M+H]+: 253.2168; found: 253.2156.
+
(1R*,2S*)-Ethyl 2-benzyl-2-butylcyclopropanecarboxylate (3y)
was prepared according to procedure E: Eluent (hexanes/Et2O
95:5); yield: 65% (colorless oil); Rf =0.39 (hexanes/Et2O=98:2); d.r.:
93:7, determined by GC analysis using Varian CP-Sil 8CB column
(injector 2808C, column oven: 708C hold for 1 min, then 58CminÀ1
until 2508C, flow: 1 mLminÀ1) tR (major)=19.8 min, tR (minor)=
19.9 min; 1H NMR (300 MHz, CDCl3, major diastereoisomer): d=
0.82 (t, J=7.1 Hz, 3H), 0.96 (dd, J=8.0, 4.5 Hz, 1H), 1.10 (dd, J=
5.6, 4.5 Hz, 1H), 1.15–1.27 (m, 6H), 1.36–1.53 (m, 3H), 1.60 (dd, J=
8.0, 5.6 Hz, 1H), 2.54 (dAB, J=14.3 Hz, 1H), 2.79 (dAB, J=14.3 Hz,
1H), 4.10 (q, J=7.1 Hz, 2H), 7.14–7.29 ppm (m, 5H); 13C NMR
(75 MHz, CDCl3): d=14.2, 14.5, 19.7, 22.8, 25.4, 29.1, 29.1, 31.5,
42.3, 60.4, 126.4, 128.3, 129.4, 138.9, 172.7 ppm; HRMS (ESI pos):
m/z calcd for C17H25O2 [M+H]+: 261.1855; found: 261.1832.
calcd for C14H25O2 [M+H]+: 225.1855; found: 225.1825.
+
(1S*,2R*)-Ethyl 2-butyl-2-propylcyclopropanecarboxylate (3u)
was prepared according to procedure C: Eluent (hexanes/Et2O
95:5); yield: 70% (colorless oil); Rf =0.63 (hexanes/Et2O 95:5);
1H NMR (CDCl3, 300 MHz): d=0.80 (dd, J=7.9, 4.3 Hz, 1H), 0.86 (t,
J=7.2 Hz, 3H), 0.88 (t, J=6.9 Hz, 3H), 1.03 (dd, J=5.6, 4.3 Hz, 1H),
1.10–1.20 (m, 2H), 1.22–1.30 (m, 6H), 1.31–1.39 (m, 4H), 1.43 (dd,
J=7.9, 5.6 Hz, 1H), 1.47–1.54 (m, 1H), 4.10 ppm (q, J=7.2 Hz, 2H);
13C NMR (CDCl3, 75 MHz): d=14.3, 14.3, 14.5, 19.6, 20.9, 23.0, 26.2,
28.5, 29.1, 31.1, 39.3, 60.3, 173.0 ppm; HRMS (ESI pos): m/z calcd
for C13H25O2 [M+H]+: 213.1855; found: 213.1845.
(1S*,2S*)-Ethyl 2-methyl-2-(4-oxooctyl)cyclopropanecarboxylate
(3z) was prepared according to procedure E: Eluent (hexanes/
AcOEt 95:5); yield: 76% (colorless oil); Rf =0.26 (hexanes/Et2O=
90:10); d.r.: 97:3, determined by GC analysis using Varian CP-Sil
8CB column (injector 2808C, column oven: 708C hold for 1 min,
then 58CminÀ1 until 2508C, flow: 1 mLminÀ1) tR (major)=19.1 min,
(1S*,3R*)-Ethyl 3-allyl-2,2-dihexylcyclopropanecarboxylate (3v)
was prepared according to procedure C: Eluent (hexanes/Et2O
95:5); yield: 65% (colorless oil); Rf =0.52 (hexanes/Et2O 95:5);
1H NMR (CDCl3, 300 MHz): d=0.84–0.90 (m, 6H), 1.17–1.19 (m, 1H),
1.21–1.39 (m, 22H), 1.40–1.50 (m, 3H), 2.04–2.23 (m, 2H), 4.10 (q,
J=7.1 Hz, 2H), 4.98 (dq, J=10.2, 1.6 Hz, 1H), 5.04 (dq, J=17.1,
1.6 Hz, 1H), 5.83 ppm (ddt, J=17.1, 10.2, 6.4 Hz, 1H); 13C NMR
(CDCl3, 75 MHz): d=14.2, 14.2, 14.5, 22.8, 22.8, 26.6, 26.6, 29.6,
29.7, 30.1, 31.6, 32.0, 32.0, 32.1, 32.3, 32.5, 36.0, 60.3, 115.1, 137.4,
1
tR (minor)=19.6 min; H NMR (300 MHz, CDCl3, major diastereoiso-
mer): d=079 (dd, J=8.1, 4.4 Hz, 1H), 0.87 (t, J=7.3 Hz, 3H), 1.02
(dd, J=5.5, 4.4 Hz, 1H), 1.14 (s, 3H), 1.18–1.33 (m, 7H), 1.43 (dd,
J=8.0, 5.5 Hz, 1H), 1.48–1.54 (m, 2H), 1.60–1.70 (m, 2H), 2.36 (t,
J=7.4 Hz, 2H), 2.37 (t, J=7.3 Hz, 2H), 4.03–4.14 ppm (m, 2H);
13C NMR (100 MHz, CDCl3): d=13.9, 14.5, 16.0, 20.8, 21.1, 22.5, 26.1,
26.4, 26.4, 40.2, 42.3, 42.7, 60.3, 172.6, 211.1 ppm; HRMS (ESI pos):
m/z calcd for C15H27O3 [M+H]+: 255.1960; found: 255.1944.
172.9 ppm; HRMS (ESI pos): m/z calcd for C12H39O2 [M+H]+:
+
323.2950; found: 323.2910.
(E)-Ethyl 4-methyldec-3-enoate (4a) was prepared according to
procedure A and then warmed to room temperature before hy-
drolysis: Eluent (hexanes/Et2O 95:5); yield: 82% isolated, 91%
without purification, suitable for analysis (colorless oil); Rf =0.48
(hexanes/Et2O 95:5); 1H NMR (CDCl3, 300 MHz): d=0.87 (t, J=
6.8 Hz, 3H), 1.22–1.32 (m, 9H), 1.34–1.44 (m, 2H), 1.61 (s, 3H),
(1S*,2S*,3R*)-Ethyl 2-butyl-2-methyl-3-[(E)-1-tosylhex-1-en-2-yl]-
cyclopropanecarboxylate (3w) was prepared according to proce-
dure B: Eluent (hexanes/Et2O 95:5); yield: 52% isolated (colorless
oil); Rf =0.15 (hexanes/Et2O 95:5); 1H NMR (CDCl3, 400 MHz): d=
0.85 (t, J=7.1 Hz, 3H), 0.90 (t, J=6.7 Hz, 3H), 0.94(s, 3H), 1.14–1.43
Chem. Eur. J. 2014, 20, 1038 – 1048
1045
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim